Sichuan Huiyu Pharmaceutical Co Ltd banner

Sichuan Huiyu Pharmaceutical Co Ltd
SSE:688553

Watchlist Manager
Sichuan Huiyu Pharmaceutical Co Ltd Logo
Sichuan Huiyu Pharmaceutical Co Ltd
SSE:688553
Watchlist
Price: 19.93 CNY -1.53% Market Closed
Market Cap: ¥8.4B

Sichuan Huiyu Pharmaceutical Co Ltd
Investor Relations

Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Neijiang, Sichuan and currently employs 1,480 full-time employees. The company went IPO on 2021-10-26. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The firm's products are mainly used in the clinical treatment of various adaptive diseases. The firm distributes its products both in the domestic market and to overseas markets.

Show more
Loading
688553
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Zhao Ding
Chairman of the Board & GM
No Bio Available
Ms. Lina Ma
Director, Deputy GM & Secretary
No Bio Available
Mr. Gang Cai
Manager of Technical Department, Quality Manager & Quality Director
No Bio Available

Contacts

Address
SICHUAN
Neijiang
No. 333, Hanyang Road, Shizhong District
Contacts
+868328808000
www.huiyupharma.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett